Article Text

Download PDFPDF
Psychological burden of anaphylaxis and the fight for an EpiPen
  1. Sara Pradhan
  1. Postgraduate Centre, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK
  1. Correspondence to Dr Sara Pradhan; s_pradhan{at}outlook.com

Abstract

A university student with a background of atopy presented to her general practitioner (GP) 2 weeks following an episode of throat tightening and dizziness occurring after touching cashew nut to her lip. She took antihistamine medication immediately and went to sleep, fearing for her life. On waking, she felt astounded to be alive. Her symptoms resolved gradually over the following week. She waited 2 weeks for an appointment with her GP, who referred her to allergy clinic. Eight months later, she was still waiting for her clinic appointment, and was left fearing a future fatal reaction, having been provided with no interim treatment. Not all patients who have severe allergic reactions present to the emergency department. Living with the constant fear of anaphylaxis can be overwhelming for patients and their families, and it can negatively impact mental health. Therefore, we advise early allergy counselling and early EpiPen prescription.

  • general practice / family medicine
  • healthcare improvement and patient safety
  • immunology
  • allergy
  • asthma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SP has taken the history and researched the case as well as conducted the write-up. A poster/oral presentation version of the paper has been accepted by the Royal College of General Practitioners (RCGP) to be presented at the RCGP Annual Conference in October 2021.

  • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer-reviewed.